ARYZTA AG

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NSRGY has a market cap of 265.1B. Regarding current trading prices, ARZTY is priced at $7.80, while NSRGY trades at $101.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NSRGY's P/E ratio is 22.62. In terms of profitability, ARZTY's ROE is +0.22%, compared to NSRGY's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to NSRGY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSRGY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NSRGF has a market cap of 263.4B. Regarding current trading prices, ARZTY is priced at $7.80, while NSRGF trades at $100.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NSRGF's P/E ratio is 22.71. In terms of profitability, ARZTY's ROE is +0.22%, compared to NSRGF's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to NSRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSRGF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, DANOY has a market cap of 52.4B. Regarding current trading prices, ARZTY is priced at $7.80, while DANOY trades at $16.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas DANOY's P/E ratio is 24.80. In terms of profitability, ARZTY's ROE is +0.22%, compared to DANOY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to DANOY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check DANOY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GPDNF has a market cap of 51B. Regarding current trading prices, ARZTY is priced at $7.80, while GPDNF trades at $79.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GPDNF's P/E ratio is 23.70. In terms of profitability, ARZTY's ROE is +0.22%, compared to GPDNF's ROE of +0.11%. Regarding short-term risk, ARZTY and GPDNF have similar daily volatility (0.00).Check GPDNF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, JBSAY has a market cap of 30.6B. Regarding current trading prices, ARZTY is priced at $7.80, while JBSAY trades at $13.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas JBSAY's P/E ratio is 6.94. In terms of profitability, ARZTY's ROE is +0.22%, compared to JBSAY's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to JBSAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check JBSAY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, AJINF has a market cap of 24.4B. Regarding current trading prices, ARZTY is priced at $7.80, while AJINF trades at $25.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas AJINF's P/E ratio is 105.75. In terms of profitability, ARZTY's ROE is +0.22%, compared to AJINF's ROE of +0.11%. Regarding short-term risk, ARZTY and AJINF have similar daily volatility (0.00).Check AJINF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ASBFF has a market cap of 19.7B. Regarding current trading prices, ARZTY is priced at $7.80, while ASBFF trades at $27.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ASBFF's P/E ratio is 14.48. In terms of profitability, ARZTY's ROE is +0.22%, compared to ASBFF's ROE of +0.09%. Regarding short-term risk, ARZTY and ASBFF have similar daily volatility (0.00).Check ASBFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, JDEPF has a market cap of 18.4B. Regarding current trading prices, ARZTY is priced at $7.80, while JDEPF trades at $38.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas JDEPF's P/E ratio is 26.21. In terms of profitability, ARZTY's ROE is +0.22%, compared to JDEPF's ROE of +0.07%. Regarding short-term risk, ARZTY and JDEPF have similar daily volatility (0.00).Check JDEPF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ASBFY has a market cap of 17.4B. Regarding current trading prices, ARZTY is priced at $7.80, while ASBFY trades at $24.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ASBFY's P/E ratio is 12.97. In terms of profitability, ARZTY's ROE is +0.22%, compared to ASBFY's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to ASBFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check ASBFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, WHGRF has a market cap of 17.3B. Regarding current trading prices, ARZTY is priced at $7.80, while WHGRF trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas WHGRF's P/E ratio is 10.38. In terms of profitability, ARZTY's ROE is +0.22%, compared to WHGRF's ROE of +0.15%. Regarding short-term risk, ARZTY is less volatile compared to WHGRF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check WHGRF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, WHGLY has a market cap of 15.6B. Regarding current trading prices, ARZTY is priced at $7.80, while WHGLY trades at $24.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas WHGLY's P/E ratio is 9.65. In terms of profitability, ARZTY's ROE is +0.22%, compared to WHGLY's ROE of +0.15%. Regarding short-term risk, ARZTY is less volatile compared to WHGLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check WHGLY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GRBMF has a market cap of 14.9B. Regarding current trading prices, ARZTY is priced at $7.80, while GRBMF trades at $3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GRBMF's P/E ratio is 23.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to GRBMF's ROE of +0.09%. Regarding short-term risk, ARZTY and GRBMF have similar daily volatility (0.00).Check GRBMF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, BMBOY has a market cap of 14.5B. Regarding current trading prices, ARZTY is priced at $7.80, while BMBOY trades at $13.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas BMBOY's P/E ratio is 23.12. In terms of profitability, ARZTY's ROE is +0.22%, compared to BMBOY's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to BMBOY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check BMBOY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, AJINY has a market cap of 14.3B. Regarding current trading prices, ARZTY is priced at $7.80, while AJINY trades at $27.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas AJINY's P/E ratio is 116.50. In terms of profitability, ARZTY's ROE is +0.22%, compared to AJINY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to AJINY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check AJINY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, KRYAF has a market cap of 13.8B. Regarding current trading prices, ARZTY is priced at $7.80, while KRYAF trades at $86.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas KRYAF's P/E ratio is 18.61. In terms of profitability, ARZTY's ROE is +0.22%, compared to KRYAF's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to KRYAF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check KRYAF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ORKLF has a market cap of 13.5B. Regarding current trading prices, ARZTY is priced at $7.80, while ORKLF trades at $13.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ORKLF's P/E ratio is 20.22. In terms of profitability, ARZTY's ROE is +0.22%, compared to ORKLF's ROE of +0.24%. Regarding short-term risk, ARZTY and ORKLF have similar daily volatility (0.00).Check ORKLF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, KRYAY has a market cap of 12.7B. Regarding current trading prices, ARZTY is priced at $7.80, while KRYAY trades at $79.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas KRYAY's P/E ratio is 17.29. In terms of profitability, ARZTY's ROE is +0.22%, compared to KRYAY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to KRYAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check KRYAY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SAPIF has a market cap of 12.5B. Regarding current trading prices, ARZTY is priced at $7.80, while SAPIF trades at $30.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SAPIF's P/E ratio is 26.91. In terms of profitability, ARZTY's ROE is +0.22%, compared to SAPIF's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to SAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check SAPIF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ORKLY has a market cap of 12.2B. Regarding current trading prices, ARZTY is priced at $7.80, while ORKLY trades at $12.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ORKLY's P/E ratio is 18.49. In terms of profitability, ARZTY's ROE is +0.22%, compared to ORKLY's ROE of +0.24%. Regarding short-term risk, ARZTY is less volatile compared to ORKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check ORKLY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SDPNF has a market cap of 10.3B. Regarding current trading prices, ARZTY is priced at $7.80, while SDPNF trades at $1.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SDPNF's P/E ratio is 16.55. In terms of profitability, ARZTY's ROE is +0.22%, compared to SDPNF's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to SDPNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check SDPNF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, LOTBY has a market cap of 10.2B. Regarding current trading prices, ARZTY is priced at $7.80, while LOTBY trades at $125.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas LOTBY's P/E ratio is 50.66. In terms of profitability, ARZTY's ROE is +0.22%, compared to LOTBY's ROE of +0.21%. Regarding short-term risk, ARZTY is less volatile compared to LOTBY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check LOTBY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, BRZL has a market cap of 10.1B. Regarding current trading prices, ARZTY is priced at $7.80, while BRZL trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas BRZL's P/E ratio is N/A. In terms of profitability, ARZTY's ROE is +0.22%, compared to BRZL's ROE of +0.91%. Regarding short-term risk, ARZTY is less volatile compared to BRZL. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check BRZL's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TYCMY has a market cap of 9.1B. Regarding current trading prices, ARZTY is priced at $7.80, while TYCMY trades at $32.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TYCMY's P/E ratio is 15.32. In terms of profitability, ARZTY's ROE is +0.22%, compared to TYCMY's ROE of +0.31%. Regarding short-term risk, ARZTY is less volatile compared to TYCMY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TYCMY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TTAZF has a market cap of 8.8B. Regarding current trading prices, ARZTY is priced at $7.80, while TTAZF trades at $7.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TTAZF's P/E ratio is 77.60. In terms of profitability, ARZTY's ROE is +0.22%, compared to TTAZF's ROE of N/A. Regarding short-term risk, ARZTY and TTAZF have similar daily volatility (0.00).Check TTAZF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CIADF has a market cap of 8.5B. Regarding current trading prices, ARZTY is priced at $7.80, while CIADF trades at $2.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CIADF's P/E ratio is -220.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to CIADF's ROE of -0.01%. Regarding short-term risk, ARZTY and CIADF have similar daily volatility (0.00).Check CIADF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, KIKOF has a market cap of 8.2B. Regarding current trading prices, ARZTY is priced at $7.80, while KIKOF trades at $8.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas KIKOF's P/E ratio is 22.56. In terms of profitability, ARZTY's ROE is +0.22%, compared to KIKOF's ROE of +0.11%. Regarding short-term risk, ARZTY and KIKOF have similar daily volatility (0.00).Check KIKOF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CIADY has a market cap of 8B. Regarding current trading prices, ARZTY is priced at $7.80, while CIADY trades at $20.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CIADY's P/E ratio is -205.47. In terms of profitability, ARZTY's ROE is +0.22%, compared to CIADY's ROE of -0.01%. Regarding short-term risk, ARZTY is less volatile compared to CIADY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check CIADY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, KIKOY has a market cap of 7.8B. Regarding current trading prices, ARZTY is priced at $7.80, while KIKOY trades at $16.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas KIKOY's P/E ratio is 21.41. In terms of profitability, ARZTY's ROE is +0.22%, compared to KIKOY's ROE of +0.12%. Regarding short-term risk, ARZTY and KIKOY have similar daily volatility (0.00).Check KIKOY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TSUKF has a market cap of 7.5B. Regarding current trading prices, ARZTY is priced at $7.80, while TSUKF trades at $77.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TSUKF's P/E ratio is 19.28. In terms of profitability, ARZTY's ROE is +0.22%, compared to TSUKF's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to TSUKF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TSUKF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TCYMF has a market cap of 7.3B. Regarding current trading prices, ARZTY is priced at $7.80, while TCYMF trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TCYMF's P/E ratio is 13.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to TCYMF's ROE of +0.31%. Regarding short-term risk, ARZTY and TCYMF have similar daily volatility (0.00).Check TCYMF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, WWNTY has a market cap of 7.1B. Regarding current trading prices, ARZTY is priced at $7.80, while WWNTY trades at $29.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas WWNTY's P/E ratio is 11.60. In terms of profitability, ARZTY's ROE is +0.22%, compared to WWNTY's ROE of +0.30%. Regarding short-term risk, ARZTY is less volatile compared to WWNTY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check WWNTY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, WWNTF has a market cap of 6.6B. Regarding current trading prices, ARZTY is priced at $7.80, while WWNTF trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas WWNTF's P/E ratio is 11.20. In terms of profitability, ARZTY's ROE is +0.22%, compared to WWNTF's ROE of +0.30%. Regarding short-term risk, ARZTY and WWNTF have similar daily volatility (0.00).Check WWNTF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ARHUF has a market cap of 6.6B. Regarding current trading prices, ARZTY is priced at $7.80, while ARHUF trades at $25.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ARHUF's P/E ratio is 17.29. In terms of profitability, ARZTY's ROE is +0.22%, compared to ARHUF's ROE of +0.18%. Regarding short-term risk, ARZTY and ARHUF have similar daily volatility (0.00).Check ARHUF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TSUKY has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $7.80, while TSUKY trades at $67.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TSUKY's P/E ratio is 16.85. In terms of profitability, ARZTY's ROE is +0.22%, compared to TSUKY's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to TSUKY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TSUKY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, MEJHY has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $7.80, while MEJHY trades at $12.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas MEJHY's P/E ratio is 22.74. In terms of profitability, ARZTY's ROE is +0.22%, compared to MEJHY's ROE of +0.06%. Regarding short-term risk, ARZTY and MEJHY have similar daily volatility (0.00).Check MEJHY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, DLLFF has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $7.80, while DLLFF trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas DLLFF's P/E ratio is 14.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to DLLFF's ROE of N/A. Regarding short-term risk, ARZTY and DLLFF have similar daily volatility (0.00).Check DLLFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GPAGF has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $7.80, while GPAGF trades at $18.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GPAGF's P/E ratio is 12.05. In terms of profitability, ARZTY's ROE is +0.22%, compared to GPAGF's ROE of +0.23%. Regarding short-term risk, ARZTY and GPAGF have similar daily volatility (0.00).Check GPAGF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GCHOY has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $7.80, while GCHOY trades at $10.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GCHOY's P/E ratio is 27.31. In terms of profitability, ARZTY's ROE is +0.22%, compared to GCHOY's ROE of +0.16%. Regarding short-term risk, ARZTY is less volatile compared to GCHOY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check GCHOY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NSLYF has a market cap of 6.4B. Regarding current trading prices, ARZTY is priced at $7.80, while NSLYF trades at $27.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NSLYF's P/E ratio is 59.35. In terms of profitability, ARZTY's ROE is +0.22%, compared to NSLYF's ROE of +0.87%. Regarding short-term risk, ARZTY is less volatile compared to NSLYF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSLYF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SGLJF has a market cap of 6.2B. Regarding current trading prices, ARZTY is priced at $7.80, while SGLJF trades at $42.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SGLJF's P/E ratio is 22.70. In terms of profitability, ARZTY's ROE is +0.22%, compared to SGLJF's ROE of +0.21%. Regarding short-term risk, ARZTY and SGLJF have similar daily volatility (0.00).Check SGLJF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NFPDF has a market cap of 5.7B. Regarding current trading prices, ARZTY is priced at $7.80, while NFPDF trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NFPDF's P/E ratio is 19.23. In terms of profitability, ARZTY's ROE is +0.22%, compared to NFPDF's ROE of +0.14%. Regarding short-term risk, ARZTY is less volatile compared to NFPDF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NFPDF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, MEJHF has a market cap of 5.5B. Regarding current trading prices, ARZTY is priced at $7.80, while MEJHF trades at $20.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas MEJHF's P/E ratio is 17.02. In terms of profitability, ARZTY's ROE is +0.22%, compared to MEJHF's ROE of +0.06%. Regarding short-term risk, ARZTY is less volatile compared to MEJHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check MEJHF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SMPFF has a market cap of 5.2B. Regarding current trading prices, ARZTY is priced at $7.80, while SMPFF trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SMPFF's P/E ratio is 13.38. In terms of profitability, ARZTY's ROE is +0.22%, compared to SMPFF's ROE of +0.24%. Regarding short-term risk, ARZTY and SMPFF have similar daily volatility (0.00).Check SMPFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PIFFY has a market cap of 5.2B. Regarding current trading prices, ARZTY is priced at $7.80, while PIFFY trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PIFFY's P/E ratio is 14.75. In terms of profitability, ARZTY's ROE is +0.22%, compared to PIFFY's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to PIFFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check PIFFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, EMLZF has a market cap of 5.2B. Regarding current trading prices, ARZTY is priced at $7.80, while EMLZF trades at $969.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas EMLZF's P/E ratio is 17.76. In terms of profitability, ARZTY's ROE is +0.22%, compared to EMLZF's ROE of +0.22%. Regarding short-term risk, ARZTY is less volatile compared to EMLZF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check EMLZF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GLAPY has a market cap of 5.1B. Regarding current trading prices, ARZTY is priced at $7.80, while GLAPY trades at $98.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GLAPY's P/E ratio is 41.80. In terms of profitability, ARZTY's ROE is +0.22%, compared to GLAPY's ROE of +0.08%. Regarding short-term risk, ARZTY and GLAPY have similar daily volatility (0.00).Check GLAPY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GLAPF has a market cap of 4.8B. Regarding current trading prices, ARZTY is priced at $7.80, while GLAPF trades at $19.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GLAPF's P/E ratio is 42.13. In terms of profitability, ARZTY's ROE is +0.22%, compared to GLAPF's ROE of +0.08%. Regarding short-term risk, ARZTY and GLAPF have similar daily volatility (0.00).Check GLAPF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, IOIOF has a market cap of 4.8B. Regarding current trading prices, ARZTY is priced at $7.80, while IOIOF trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas IOIOF's P/E ratio is 12.64. In terms of profitability, ARZTY's ROE is +0.22%, compared to IOIOF's ROE of +0.13%. Regarding short-term risk, ARZTY and IOIOF have similar daily volatility (0.00).Check IOIOF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CFEIY has a market cap of 4.5B. Regarding current trading prices, ARZTY is priced at $7.80, while CFEIY trades at $4.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CFEIY's P/E ratio is 11.88. In terms of profitability, ARZTY's ROE is +0.22%, compared to CFEIY's ROE of +0.10%. Regarding short-term risk, ARZTY and CFEIY have similar daily volatility (0.00).Check CFEIY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TATYY has a market cap of 4.5B. Regarding current trading prices, ARZTY is priced at $7.80, while TATYY trades at $19.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TATYY's P/E ratio is 52.94. In terms of profitability, ARZTY's ROE is +0.22%, compared to TATYY's ROE of +0.02%. Regarding short-term risk, ARZTY and TATYY have similar daily volatility (0.00).Check TATYY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ACOPF has a market cap of 4.5B. Regarding current trading prices, ARZTY is priced at $7.80, while ACOPF trades at $6.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ACOPF's P/E ratio is 34.44. In terms of profitability, ARZTY's ROE is +0.22%, compared to ACOPF's ROE of +0.16%. Regarding short-term risk, ARZTY is less volatile compared to ACOPF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check ACOPF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PIFMF has a market cap of 4.4B. Regarding current trading prices, ARZTY is priced at $7.80, while PIFMF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PIFMF's P/E ratio is 10.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to PIFMF's ROE of +0.11%. Regarding short-term risk, ARZTY and PIFMF have similar daily volatility (0.00).Check PIFMF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NIPMY has a market cap of 4B. Regarding current trading prices, ARZTY is priced at $7.80, while NIPMY trades at $21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NIPMY's P/E ratio is 20.39. In terms of profitability, ARZTY's ROE is +0.22%, compared to NIPMY's ROE of +0.06%. Regarding short-term risk, ARZTY and NIPMY have similar daily volatility (0.00).Check NIPMY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CHFLF has a market cap of 4B. Regarding current trading prices, ARZTY is priced at $7.80, while CHFLF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CHFLF's P/E ratio is 11.24. In terms of profitability, ARZTY's ROE is +0.22%, compared to CHFLF's ROE of +0.10%. Regarding short-term risk, ARZTY is less volatile compared to CHFLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check CHFLF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, YMZBY has a market cap of 3.6B. Regarding current trading prices, ARZTY is priced at $7.80, while YMZBY trades at $180.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas YMZBY's P/E ratio is 14.08. In terms of profitability, ARZTY's ROE is +0.22%, compared to YMZBY's ROE of +0.10%. Regarding short-term risk, ARZTY is less volatile compared to YMZBY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check YMZBY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CRWKF has a market cap of 3.4B. Regarding current trading prices, ARZTY is priced at $7.80, while CRWKF trades at $63.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CRWKF's P/E ratio is 23.79. In terms of profitability, ARZTY's ROE is +0.22%, compared to CRWKF's ROE of +0.15%. Regarding short-term risk, ARZTY is less volatile compared to CRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check CRWKF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NSFMF has a market cap of 3.3B. Regarding current trading prices, ARZTY is priced at $7.80, while NSFMF trades at $11.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NSFMF's P/E ratio is 14.20. In terms of profitability, ARZTY's ROE is +0.22%, compared to NSFMF's ROE of +0.05%. Regarding short-term risk, ARZTY is less volatile compared to NSFMF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSFMF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FPAFF has a market cap of 3.3B. Regarding current trading prices, ARZTY is priced at $7.80, while FPAFF trades at $0.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FPAFF's P/E ratio is 4.53. In terms of profitability, ARZTY's ROE is +0.22%, compared to FPAFF's ROE of +0.17%. Regarding short-term risk, ARZTY is less volatile compared to FPAFF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check FPAFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, EBRPF has a market cap of 3.3B. Regarding current trading prices, ARZTY is priced at $7.80, while EBRPF trades at $21.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas EBRPF's P/E ratio is 14.19. In terms of profitability, ARZTY's ROE is +0.22%, compared to EBRPF's ROE of +0.09%. Regarding short-term risk, ARZTY and EBRPF have similar daily volatility (0.00).Check EBRPF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FPAFY has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $7.80, while FPAFY trades at $3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FPAFY's P/E ratio is 4.45. In terms of profitability, ARZTY's ROE is +0.22%, compared to FPAFY's ROE of +0.17%. Regarding short-term risk, ARZTY is less volatile compared to FPAFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check FPAFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TBLMF has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $7.80, while TBLMF trades at $20.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TBLMF's P/E ratio is 12.97. In terms of profitability, ARZTY's ROE is +0.22%, compared to TBLMF's ROE of +0.21%. Regarding short-term risk, ARZTY is less volatile compared to TBLMF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TBLMF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PIFMY has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $7.80, while PIFMY trades at $18.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PIFMY's P/E ratio is 6.90. In terms of profitability, ARZTY's ROE is +0.22%, compared to PIFMY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to PIFMY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check PIFMY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NHFOF has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $7.80, while NHFOF trades at $33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NHFOF's P/E ratio is 18.54. In terms of profitability, ARZTY's ROE is +0.22%, compared to NHFOF's ROE of +0.06%. Regarding short-term risk, ARZTY is less volatile compared to NHFOF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NHFOF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, LYSFY has a market cap of 3.1B. Regarding current trading prices, ARZTY is priced at $7.80, while LYSFY trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas LYSFY's P/E ratio is 80.77. In terms of profitability, ARZTY's ROE is +0.22%, compared to LYSFY's ROE of +0.02%. Regarding short-term risk, ARZTY and LYSFY have similar daily volatility (0.00).Check LYSFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, LYSFF has a market cap of 3.1B. Regarding current trading prices, ARZTY is priced at $7.80, while LYSFF trades at $5.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas LYSFF's P/E ratio is 86.42. In terms of profitability, ARZTY's ROE is +0.22%, compared to LYSFF's ROE of +0.02%. Regarding short-term risk, ARZTY is less volatile compared to LYSFF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check LYSFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NCHEY has a market cap of 3.1B. Regarding current trading prices, ARZTY is priced at $7.80, while NCHEY trades at $12.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NCHEY's P/E ratio is 18.06. In terms of profitability, ARZTY's ROE is +0.22%, compared to NCHEY's ROE of +0.10%. Regarding short-term risk, ARZTY is less volatile compared to NCHEY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NCHEY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PRBZF has a market cap of 3B. Regarding current trading prices, ARZTY is priced at $7.80, while PRBZF trades at $67.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PRBZF's P/E ratio is 62.82. In terms of profitability, ARZTY's ROE is +0.22%, compared to PRBZF's ROE of +0.04%. Regarding short-term risk, ARZTY is less volatile compared to PRBZF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check PRBZF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, MRRTY has a market cap of 2.9B. Regarding current trading prices, ARZTY is priced at $7.80, while MRRTY trades at $3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas MRRTY's P/E ratio is 11.03. In terms of profitability, ARZTY's ROE is +0.22%, compared to MRRTY's ROE of +0.82%. Regarding short-term risk, ARZTY is less volatile compared to MRRTY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check MRRTY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FSRCY has a market cap of 2.9B. Regarding current trading prices, ARZTY is priced at $7.80, while FSRCY trades at $184.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FSRCY's P/E ratio is 9.81. In terms of profitability, ARZTY's ROE is +0.22%, compared to FSRCY's ROE of +0.21%. Regarding short-term risk, ARZTY is less volatile compared to FSRCY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check FSRCY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CBCFF has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $7.80, while CBCFF trades at $23.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CBCFF's P/E ratio is 21.90. In terms of profitability, ARZTY's ROE is +0.22%, compared to CBCFF's ROE of +0.08%. Regarding short-term risk, ARZTY is less volatile compared to CBCFF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check CBCFF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FTROF has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $7.80, while FTROF trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FTROF's P/E ratio is 9.47. In terms of profitability, ARZTY's ROE is +0.22%, compared to FTROF's ROE of +0.21%. Regarding short-term risk, ARZTY and FTROF have similar daily volatility (0.00).Check FTROF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, EBRPY has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $7.80, while EBRPY trades at $17.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas EBRPY's P/E ratio is 20.34. In terms of profitability, ARZTY's ROE is +0.22%, compared to EBRPY's ROE of +0.06%. Regarding short-term risk, ARZTY and EBRPY have similar daily volatility (0.00).Check EBRPY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, NISUY has a market cap of 2.6B. Regarding current trading prices, ARZTY is priced at $7.80, while NISUY trades at $86.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas NISUY's P/E ratio is 15.67. In terms of profitability, ARZTY's ROE is +0.22%, compared to NISUY's ROE of +0.10%. Regarding short-term risk, ARZTY and NISUY have similar daily volatility (0.00).Check NISUY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, MLFNF has a market cap of 2.6B. Regarding current trading prices, ARZTY is priced at $7.80, while MLFNF trades at $20.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas MLFNF's P/E ratio is 83.92. In terms of profitability, ARZTY's ROE is +0.22%, compared to MLFNF's ROE of +0.35%. Regarding short-term risk, ARZTY is less volatile compared to MLFNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check MLFNF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, UVRBF has a market cap of 2.5B. Regarding current trading prices, ARZTY is priced at $7.80, while UVRBF trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas UVRBF's P/E ratio is 11.80. In terms of profitability, ARZTY's ROE is +0.22%, compared to UVRBF's ROE of +0.10%. Regarding short-term risk, ARZTY and UVRBF have similar daily volatility (0.00).Check UVRBF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SUEZF has a market cap of 2.4B. Regarding current trading prices, ARZTY is priced at $7.80, while SUEZF trades at $11.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SUEZF's P/E ratio is -11.15. In terms of profitability, ARZTY's ROE is +0.22%, compared to SUEZF's ROE of -0.06%. Regarding short-term risk, ARZTY is less volatile compared to SUEZF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check SUEZF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, SUEZY has a market cap of 2.3B. Regarding current trading prices, ARZTY is priced at $7.80, while SUEZY trades at $5.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas SUEZY's P/E ratio is -10.44. In terms of profitability, ARZTY's ROE is +0.22%, compared to SUEZY's ROE of -0.06%. Regarding short-term risk, ARZTY and SUEZY have similar daily volatility (0.00).Check SUEZY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, CLBEY has a market cap of 2.3B. Regarding current trading prices, ARZTY is priced at $7.80, while CLBEY trades at $4.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas CLBEY's P/E ratio is 21.14. In terms of profitability, ARZTY's ROE is +0.22%, compared to CLBEY's ROE of +0.08%. Regarding short-term risk, ARZTY and CLBEY have similar daily volatility (0.00).Check CLBEY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, UVRBY has a market cap of 2.2B. Regarding current trading prices, ARZTY is priced at $7.80, while UVRBY trades at $10.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas UVRBY's P/E ratio is 11.01. In terms of profitability, ARZTY's ROE is +0.22%, compared to UVRBY's ROE of +0.10%. Regarding short-term risk, ARZTY and UVRBY have similar daily volatility (0.00).Check UVRBY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PFODF has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $7.80, while PFODF trades at $2.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PFODF's P/E ratio is 12.40. In terms of profitability, ARZTY's ROE is +0.22%, compared to PFODF's ROE of +0.11%. Regarding short-term risk, ARZTY and PFODF have similar daily volatility (0.00).Check PFODF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TATYF has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $7.80, while TATYF trades at $4.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TATYF's P/E ratio is 52.33. In terms of profitability, ARZTY's ROE is +0.22%, compared to TATYF's ROE of +0.02%. Regarding short-term risk, ARZTY and TATYF have similar daily volatility (0.00).Check TATYF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GRPBF has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $7.80, while GRPBF trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GRPBF's P/E ratio is N/A. In terms of profitability, ARZTY's ROE is +0.22%, compared to GRPBF's ROE of N/A. Regarding short-term risk, ARZTY and GRPBF have similar daily volatility (0.00).Check GRPBF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, PRRFY has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $7.80, while PRRFY trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas PRRFY's P/E ratio is 12.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to PRRFY's ROE of +0.15%. Regarding short-term risk, ARZTY is less volatile compared to PRRFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check PRRFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, ARZTF has a market cap of 1.9B. Regarding current trading prices, ARZTY is priced at $7.80, while ARZTF trades at $62.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas ARZTF's P/E ratio is 522.33. In terms of profitability, ARZTY's ROE is +0.22%, compared to ARZTF's ROE of +0.23%. Regarding short-term risk, ARZTY and ARZTF have similar daily volatility (0.00).Check ARZTF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, HOFJF has a market cap of 1.8B. Regarding current trading prices, ARZTY is priced at $7.80, while HOFJF trades at $19.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas HOFJF's P/E ratio is 23.90. In terms of profitability, ARZTY's ROE is +0.22%, compared to HOFJF's ROE of +0.04%. Regarding short-term risk, ARZTY is less volatile compared to HOFJF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check HOFJF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GNCGF has a market cap of 1.8B. Regarding current trading prices, ARZTY is priced at $7.80, while GNCGF trades at $4.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GNCGF's P/E ratio is 24.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to GNCGF's ROE of +0.12%. Regarding short-term risk, ARZTY and GNCGF have similar daily volatility (0.00).Check GNCGF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TBLMY has a market cap of 1.7B. Regarding current trading prices, ARZTY is priced at $7.80, while TBLMY trades at $10.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TBLMY's P/E ratio is 12.02. In terms of profitability, ARZTY's ROE is +0.22%, compared to TBLMY's ROE of +0.17%. Regarding short-term risk, ARZTY and TBLMY have similar daily volatility (0.00).Check TBLMY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, AVSFY has a market cap of 1.7B. Regarding current trading prices, ARZTY is priced at $7.80, while AVSFY trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas AVSFY's P/E ratio is 12.32. In terms of profitability, ARZTY's ROE is +0.22%, compared to AVSFY's ROE of +0.46%. Regarding short-term risk, ARZTY and AVSFY have similar daily volatility (0.00).Check AVSFY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GNCGY has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $7.80, while GNCGY trades at $14.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GNCGY's P/E ratio is 20.43. In terms of profitability, ARZTY's ROE is +0.22%, compared to GNCGY's ROE of +0.12%. Regarding short-term risk, ARZTY and GNCGY have similar daily volatility (0.00).Check GNCGY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, YNNHF has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $7.80, while YNNHF trades at $1.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas YNNHF's P/E ratio is 14.25. In terms of profitability, ARZTY's ROE is +0.22%, compared to YNNHF's ROE of +0.16%. Regarding short-term risk, ARZTY and YNNHF have similar daily volatility (0.00).Check YNNHF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FNEVY has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $7.80, while FNEVY trades at $5.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FNEVY's P/E ratio is 13.00. In terms of profitability, ARZTY's ROE is +0.22%, compared to FNEVY's ROE of +0.05%. Regarding short-term risk, ARZTY and FNEVY have similar daily volatility (0.00).Check FNEVY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, FNEVF has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $7.80, while FNEVF trades at $1.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas FNEVF's P/E ratio is 12.75. In terms of profitability, ARZTY's ROE is +0.22%, compared to FNEVF's ROE of +0.05%. Regarding short-term risk, ARZTY is less volatile compared to FNEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check FNEVF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TUFBY has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $7.80, while TUFBY trades at $7.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TUFBY's P/E ratio is 10.05. In terms of profitability, ARZTY's ROE is +0.22%, compared to TUFBY's ROE of +0.10%. Regarding short-term risk, ARZTY and TUFBY have similar daily volatility (0.00).Check TUFBY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GUZOF has a market cap of 1.4B. Regarding current trading prices, ARZTY is priced at $7.80, while GUZOF trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GUZOF's P/E ratio is 14.52. In terms of profitability, ARZTY's ROE is +0.22%, compared to GUZOF's ROE of +0.30%. Regarding short-term risk, ARZTY and GUZOF have similar daily volatility (0.00).Check GUZOF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, HLFGY has a market cap of 1.4B. Regarding current trading prices, ARZTY is priced at $7.80, while HLFGY trades at $15.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas HLFGY's P/E ratio is 24.16. In terms of profitability, ARZTY's ROE is +0.22%, compared to HLFGY's ROE of +0.14%. Regarding short-term risk, ARZTY is less volatile compared to HLFGY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check HLFGY's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, AKEJF has a market cap of 1.2B. Regarding current trading prices, ARZTY is priced at $7.80, while AKEJF trades at $37.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas AKEJF's P/E ratio is 18.28. In terms of profitability, ARZTY's ROE is +0.22%, compared to AKEJF's ROE of +0.05%. Regarding short-term risk, ARZTY is less volatile compared to AKEJF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check AKEJF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, TUFUF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $7.80, while TUFUF trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas TUFUF's P/E ratio is 7.31. In terms of profitability, ARZTY's ROE is +0.22%, compared to TUFUF's ROE of +0.10%. Regarding short-term risk, ARZTY is less volatile compared to TUFUF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TUFUF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, JWLLF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $7.80, while JWLLF trades at $26.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas JWLLF's P/E ratio is 24.68. In terms of profitability, ARZTY's ROE is +0.22%, compared to JWLLF's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to JWLLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check JWLLF's competition here

ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARZTY stands at 1.9B. In comparison, GBFBF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $7.80, while GBFBF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARZTY currently has a P/E ratio of 15.60, whereas GBFBF's P/E ratio is 12.38. In terms of profitability, ARZTY's ROE is +0.22%, compared to GBFBF's ROE of N/A. Regarding short-term risk, ARZTY and GBFBF have similar daily volatility (0.00).Check GBFBF's competition here